MON-297 Withdrawal from Long-Acting Somatostatin Receptor Ligand Injections in Adult Patients with Acromegaly: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study

Data on the impact of withdrawal from long-acting somatostatin receptor ligand (SRL) injections on disease activity in patients with acromegaly are limited. The phase 3 Octreotide capsules versus Placebo Treatment In MultinationAL centers (OPTIMAL) study assessed the efficacy and safety of oral octr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nachtigall, Lisa B, Samson, Susan Leanne, Fleseriu, Maria, Bolanowski, Marek, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Manning, Patrick, Biermasz, Nienke, Giustina, Andrea, Strasburger, Christian Joseph, Melmed, Shlomo, Kennedy, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207850/
http://dx.doi.org/10.1210/jendso/bvaa046.1833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207850/
http://dx.doi.org/10.1210/jendso/bvaa046.1833

Ejemplares similares